Product Code: RP-ID-10336493 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10336493
Market Overview:
Global Softgel Capsules Market Size study, by Product (Gelatin Soft gel Capsules, Vegetarian Softgel Capsules ), by Application ( Antacid and Antiflatulent Preparations, Antianemic Preparations (Hematenic Preparations), Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Cardiovascular Therapy Drugs, Health supplement, Vitamins and Dietary Supplements, Other Therapeutic Applications), by Raw Material (Type-A Gelatin (Pork Skin),
Global Softgel Capsules Market is valued approximately at USD 2.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.46% over the forecast period 2020-2027. A softgel consists of a gel-based layer containing a liquid or semi-solid (inner filling) drug or extract in the core. Softgel capsules deliver a range of advantages to customers, such as comfort, improved potency and bioavailability. Investments by companies in research and development activities and technical advances have contributed to the growth and use of other outlets for the processing of softgel capsules, which are vegetarian in nature, and also have streamlined manufacturing processes for softgel capsules. The softgel capsules have substituted other capsules which are hard to make. This, in fact, has driven the expansion of the market over the last few years and is expected to show a similar pattern in the foreseeable future. Rising demand from health-conscious customers and the introduction of emerging technology by manufacturers to boost the market growth. Apart from this, rising applications of Softgel Capsules In Nutraceutical Industries along with increasing investments by major market players in Capsule Manufacturing Plants is expected to create significant growth opportunity in the market over the forecast period. For instance, on April 2019, Catalent announced investment of about USD 14 million in the softgel manufacturing facility. Similarly, in September 2019, Strides acquired US capsule facility and announced investment of about USD 10 million to increase the softgel capsule manufacturing facilities. However, high cost of vegetarian capsules and fluctuating prices of raw materials is expected to hamper the market growth.
The regional analysis of global Softgel Capsules market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to existence of a vast pharmaceutical sector and a massive pool of health-conscious consumers. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as increased healthcare expenditure and rapid expansion of the pharmaceutical would create lucrative growth prospects for the Softgel Capsules market across Asia-Pacific region.
Major market player included in this report are:
Aenova Group GmbH
Capsugel
Fuji Capsule Co., Ltd.
Sirio Pharma Company Limited
Captek Softgel International Inc
Catalent, Inc.
EuroCaps Ltd (part of DCC Plc)
Guangdong Yichao Biological Co., Ltd
Elnova Pharma
Hunan Er-Kang Pharmaceutical Co., Ltd
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Gelatin Soft gel Capsules
Vegetarian Softgel Capsules
By Application:
Antacid and Antiflatulent Preparations
Antianemic Preparations (Hematenic Preparations)
Anti-Inflammatory Drugs
Antibiotic and Antibacterial Drugs
Cough and Cold Preparations
Cardiovascular Therapy Drugs
Health supplement
Vitamins and Dietary Supplements
Other Therapeutic Applications
By Raw Material :
Type-A Gelatin (Pork Skin)
Type-B Gelatin
Fish Bone Gelatin
Hydroxy Propyl Methyl Cellulose (HPMC)
Starch Material
Pullulan
By End User :
Pharmaceutical Companies
Nutraceutical Companies
Cosmeceutical Companies
Contract Manufacturing Organizations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Softgel Capsules Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Aenova Group GmbH
Capsugel
Fuji Capsule Co., Ltd.
Sirio Pharma Company Limited
Captek Softgel International Inc
Catalent, Inc.
EuroCaps Ltd (part of DCC Plc)
Guangdong Yichao Biological Co., Ltd
Elnova Pharma
Hunan Er-Kang Pharmaceutical Co., Ltd
Related Reports
Proof of Quality & Reliability
